Skip to content

Right Iliac Fossa Treatment-Turkey Audit

Right Iliac Fossa Treatment-Turkey Audit

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04614649
Acronym
RIFT-Turkey
Enrollment
3358
Registered
2020-11-04
Start date
2020-09-10
Completion date
2021-03-01
Last updated
2024-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Pain, Appendicitis, Appendicitis Acute

Keywords

appendicitis, appendectomy, right iliac fossa, abdominal pain

Brief summary

Background: Acute appendicitis stands out as a frequently encountered surgical emergency. Despite decades of experience and research, the diagnosis remains a formidable challenge, particularly in young females experiencing acute abdominal pain, where the assessment requires consideration of a broader spectrum of potential causes. An overarching concern lies in the risk of over-treatment, leading to an escalation in unnecessary surgeries, known as the negative appendectomy rate (NAR). This elevated NAR is associated with postoperative complications, prolonged hospital stays, and avoidable healthcare expenditures. Despite international guidelines recommending the routine use of risk prediction models for patients with acute abdominal pain, reported NAR values have reached as high as 28.2% in females and 12.1% in males. Aim: The primary study aim is to identify optimal risk prediction models for acute RIF pain in Turkey. The secondary aims are to audit the normal appendicectomy rate, assess whether these scores have similar efficacy in immigrants, and demonstrate nationwide clinical trends to discuss possible improvements.

Interventions

None listed

Sponsors

Gazi University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All consecutive patients referred to general surgeons with right iliac fossa pain or suspected appendicitis. * All patients who undergo an appendicectomy during the study period.

Exclusion criteria

* Previous appendicectomy, right hemicolectomy, or total colectomy. * Previous abdominal surgery in the last 90 days. * Pregnancy. * Patients confirmed with COVID-19.

Design outcomes

Primary

MeasureTime frameDescription
Best classification performance among 4 appendicitis scoring systems (for Turkish population)During admissionData is used to calculate the four most commonly used adult risk prediction models: Alvarado, the Appendicitis Inflammatory Response (AIR), Raja Isteri Pengiran Anak Saleha Appendicitis (RIPASA), and Adult Appendicitis Score (AAS). Then, the performance of each scoring system will be compared with one another to find the best scoring system among them.

Secondary

MeasureTime frameDescription
Normal Appendicectomy Rate (NAR)All patients are followed up for 60 days, and data being utilized for NAR calculation is collected within that timeframe.The NAR value is calculated as the percentage of patients with normal appendix histology who had undergone appendectomy. Patients with appendix pathology other than appendicitis (such as appendix tumor) were included in the denominator but not the numerator.
Best classification performance among 4 appendicitis scoring systems (for immigrant population)During admissionData is used to calculate the four most commonly used adult risk prediction models: Alvarado, the Appendicitis Inflammatory Response (AIR), Raja Isteri Pengiran Anak Saleha Appendicitis (RIPASA), and Adult Appendicitis Score (AAS). Then, the performance of each scoring system will be compared with one another to find the best scoring system among them.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026